Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...